Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Nov;9(Suppl 15):S1442-S1447.
doi: 10.21037/jtd.2017.01.59.

Lung neuroendocrine tumors: pathological characteristics

Luisella Righi  1 , Gaia Gatti  1 , Marco Volante  1 , Mauro Papotti  2
Affiliations
Review

Lung neuroendocrine tumors: pathological characteristics

Luisella Righi et al. J Thorac Dis. 2017 Nov.

Abstract

Lung neuroendocrine tumors (NETs) are a heterogeneous family of neoplasms comprising four histologic types, namely typical and atypical carcinoid (TC and AC), large-cell neuroendocrine and small cell carcinoma (SCC). Classification criteria include the number of mitoses per 2 mm2, the occurrence and extent of necrosis, cytological and histological features and immunohistochemistry for neuroendocrine markers. The classification system and the diagnostic workflow of lung NETs are apparently easy to apply and well established. However, several unresolved issues still exist in classification and pathological characterization of these tumors, probably because inter-observer diagnostic reproducibility remains disappointing, likely due to inconsistency in recognizing necrosis, mitoses and cytological details, especially in small biopsy or cytological materials. Furthermore, the lack of strong prognostic and grading criteria leads to the incomplete interpretation of some rare intermediate entities that stand in between AC and large cell neuroendocrine carcinoma (LCNEC) categories.

Keywords: Neuroendocrine; carcinoid; classification; grading; small cell carcinoma (SCC).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Representative pictures of the four histologic variants of lung neuroendocrine tumors. (A) Typical carcinoid (TC) (ematoxilin & eosin, 20×); (B) atypical carcinoid (AC) (ematoxilin & eosin, 20×); (C) large cell neuroendocrine carcinoma (LCNEC) (ematoxilin & eosin, 10×); (D) small cell carcinoma (SCC) (ematoxilin & eosin, 10×).
Figure 2
Figure 2
Pictures of a bioptical sample of lung neuroendocrine tumor. (A) Bronchial biopsy sample with low grade neuroendocrine tumor with no necrosis, no mitosis and neuroendocrine morphology (ematoxilin & eosin, 4×); (B) Ki-67 staining showed an intermediate proliferative activity (LI =10%) (immunostaining, 4×).
See this image and copyright information in PMC

References

    1. Travis WD, Brambilla E, Burke AP, et al. WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. World Healt Organization Classification Tumours. Fourth edition. Lyon: IARC Press, 2015. - PubMed
    1. Pelosi G, Fabbri A, Cossa M, et al. What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms? Semin Diagn Pathol 2015;32:469-79. 10.1053/j.semdp.2015.10.009 - DOI - PubMed
    1. Travis WD, Brambilla E, Müller-Hermelink HK, et al. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. World Healt Organization Classification Tumours 7. Lyon: IARC Press, 2004.
    1. Volante M, Gatti G, Papotti M. Classification of lung neuroendocrine tumors: lights and shadows. Endocrine 2015;50:315-9. 10.1007/s12020-015-0578-x - DOI - PubMed
    1. Skov BG, Krasnik M, Lantuejoul S, et al. Reclassification of neuroendocrine tumors improves the separation of carcinoids and the prediction of survival. J Thorac Oncol 2008;3:1410-5. 10.1097/JTO.0b013e31818e0dd4 - DOI - PubMed